The choices in the drug development model to navigate clinical pathways, and the relationship between drug developers and CROs/ CDMOs can be incredibly complex. Understanding the different ramifications of certain choices can be a minefield. This is why Ali Pashazadeh, Treehill Partners CEO, in the final part of his interview with Louis Garguilo, chief editor, Outsourced Pharma, uses a range of analogies, from buying, selling and developing cars to cooking, and specifically unscrambling an egg whilst walking backwards.
Read the full article on Outsourced Pharma:
https://www.outsourcedpharma.com/doc/biopharma-outsourcing-analogs-from-cars-to-eggs-0001